Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
This study is currently recruiting participants.
Verified June 2011
by Ann & Robert H Lurie Children's Hospital of Chicago
Study NCT01088035 Information provided by Ann & Robert H Lurie Children's Hospital of Chicago
First Received on March 16, 2010. Last Updated on June 21, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ependymoma
Additional conditions recognized in this trial
Neoplasm, Residual
More general conditions related to this trial
Glioma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neoplastic Processes
Neuroectodermal Tumors
Pathologic Processes
Interventions listed in this trial
Carboplatin
Additional drug interventions recognized in this trial
Radiation-Sensitizing Agents
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Ann & Robert H Lurie Children's Hospital of Chicago
Brown University
Back to top of Main Content